DGAP-News: SolarWorld AG / Key word(s): Incoming Orders SolarWorld AG: SolarWorld AG delivers 20 MW for large-scale project in Senegal 31.10.2016 / 14:51 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- SolarWorld AG is delivering solar modules with a capacity of 20 megawatts for a ground-mounted system in West African Senegal. The 77,280 multicrystalline solar modules will be installed in the Kahone region, about 100 kilometers from the capital Dakar, by March 2017. The contract in Senegal was acquired by the Austrian SolarWorld partner Energie Merl, which has been actively involved on the African continent for many years. The project was tendered by the Senegalese power company Senelec. "The quality of the SolarWorld solar modules is reflected in the peak yield and long service life. Through a high degree of automation and careful material selection, we enable long-term value retention, thereby reducing electricity generation costs for our customers," explains Dr.-Ing. E. h. Frank Asbeck, CEO of SolarWorld AG. The PV system is one of the largest in the country, which is characterized by rapid population growth. Frequent droughts have led to a rural exodus. As a result, energy demand in the cities is increasing rapidly. In light of the effects of climate change, including on the West African country, photovoltaics offer the key to sustainably transforming the energy supply. "With this project, we are once again documenting that photovoltaics represent a safe, clean and affordable solution for millions of people. It is a wise decision that the customer has bet on sustainability with durable products," says Asbeck. SolarWorld REAL VALUE: SolarWorld manufactures and sells high-tech solar power solutions and in doing so contributes to a cleaner energy supply worldwide. The group, headquartered in Bonn, Germany, employs 3,828 people and operates facilities in Freiberg, Germany; Arnstadt, Germany; and Hillsboro, Oregon, USA as well as in a joint venture with Qatar Solar Technologies. From raw material silicon to solar wafers, cells and modules, SolarWorld manages all stages of production ‒ including research and development in its own company, SolarWorld Innovations. Through an international distribution network with locations in Europe, USA, Singapore, Japan, South Africa and Qatar, SolarWorld supplies customers all over the world. The company upholds high social standards and commits itself to resource- and energy-efficient production. SolarWorld was founded in 1998 and has been publicly traded on the stock market since 1999. More information at www.solarworld.com Contact: SolarWorld AG Timo Glatz Martin-Luther-King-Str. 24 53175 Bonn/Germany Phone: +49 228 55920-409; Email: press@solarworld.com; Web: www.solarworld.com --------------------------------------------------------------------------- 31.10.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: SolarWorld AG Martin-Luther-King-Straße 24 53175 Bonn Germany Phone: +49 (0)228 - 559 20 470 Fax: +49 (0)228 - 559 20 9470 E-mail: placement@solarworld.com Internet: www.solarworld.de ISIN: DE000A1YCMM2, DE000A1YDDX6, DE000A1YCN14 WKN: A1YCMM, A1YDDX, A1YCN1 Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange End of News DGAP News Service --------------------------------------------------------------------------- 516049 31.10.2016
DGAP-News: SolarWorld AG: SolarWorld AG delivers 20 MW for
Top 10 Most Recent News Articles
WHO and RCSI Bahrain Join Forces on Health Initiatives
Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...
Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine
Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...
Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes
Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....
Continue Reading
Webull Faces Class Action: Key Details for Investors
What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...
Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early
Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...
Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion
Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...
Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices
Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...
Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG
New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...
Continue Reading